April 12, 2023
Shionogi said on April 11 that regulatory authorities in Taiwan have accepted for review an application seeking emergency use authorization for Xocova (ensitrelvir) for the treatment of COVID-19. This is the second regulatory submission for Xocova outside Japan, only after...read more